BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/8/2023 9:38:25 AM | Browse: 195 | Download: 603
 |
Received |
|
2023-05-16 12:26 |
|
Peer-Review Started |
|
2023-05-16 12:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-18 07:15 |
|
Revised |
|
2023-07-18 12:51 |
|
Second Decision |
|
2023-08-16 02:59 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-08-17 02:38 |
|
Articles in Press |
|
2023-08-17 02:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-08-28 08:45 |
|
Publish the Manuscript Online |
|
2023-09-08 09:38 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Comparing the efficacy of regen-cov, remdesivir, and favipiravir in reducing invasive mechanical ventilation need in hospitalized COVID-19 patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sahar Kmal Hegazy, Samar Tharwat and Ahmed Hosny Hassan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ahmed Hosny Hassan, BPharm, PharmD, Pharmacist, Researcher, Clinical pharmacy, Mansoura university hospital , No. 2 Street, El-gomhoria, Mansoura 35511, Egypt. ahmedony26@gmail.com |
| Key Words |
Antivirals; Casirivimab and imdevimab; Coronavirus disease 2019; Favipiravir; Remdesivir |
| Core Tip |
This research can benefit the coronavirus disease 2019 (COVID-19) patients by determining the most appropriate antiviral drug according to the case. This study may change the protocol of treatment of COVID-19 patients. Casirivimab and imdevimab achieve better clinical outcomes than remdesivir and favipiravir. |
| Publish Date |
2023-09-08 09:38 |
| Citation |
Hegazy SK, Tharwat S, Hassan AH. Comparing the efficacy of regen-cov, remdesivir, and favipiravir in reducing invasive mechanical ventilation need in hospitalized COVID-19 patients. World J Clin Cases 2023; 11(26): 6105-6121 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i26/6105.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i26.6105 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
